Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,490 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $620.44 | 51 | $0 (2023) |
| Novo Nordisk Inc | $202.08 | 13 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $119.61 | 2 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $107.74 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $106.11 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.85 | 4 | $0 (2024) |
| Lilly USA, LLC | $62.95 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $39.22 | 3 | $0 (2023) |
| Boston Scientific Corporation | $37.21 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $31.44 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.60 | 8 | Novartis Pharmaceuticals Corporation ($90.48) |
| 2023 | $264.67 | 24 | ABBVIE INC. ($250.72) |
| 2022 | $648.93 | 38 | ABBVIE INC. ($225.48) |
| 2021 | $409.99 | 22 | AbbVie Inc. ($144.24) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $37.21 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: DIABETES | ||||||
| 03/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Respiratory | ||||||
| 05/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 688 | 1,015 | $183,176 | $55,068 |
| 2022 | 3 | 139 | 147 | $21,470 | $6,400 |
| 2021 | 2 | 116 | 131 | $13,854 | $3,282 |
| 2020 | 1 | 19 | 20 | $3,000 | $706.60 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 453 | $105,096 | $28,571 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 241 | $44,585 | $11,908 | 26.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 64 | 64 | $18,560 | $8,433 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $7,954 | $4,172 | 52.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $896.00 | $878.08 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $560.00 | $466.72 | 83.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 41 | $2,132 | $342.02 | 16.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 39 | 48 | $1,824 | $154.08 | 8.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 32 | $1,024 | $109.12 | 10.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 50 | $500.00 | $18.32 | 3.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 15 | $45.00 | $16.17 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 65 | $15,080 | $4,954 | 32.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 37 | 37 | $5,550 | $1,301 | 23.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 37 | 45 | $840.00 | $144.85 | 17.2% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 86 | 89 | $13,350 | $3,144 | 23.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 30 | 42 | $504.00 | $137.76 | 27.3% |
| 87426 | Coronavirus ag ia | Office | 2020 | 19 | 20 | $3,000 | $706.60 | 23.6% |
About Marina Turner, FNP-BC
Marina Turner, FNP-BC is a Family healthcare provider based in Nags Head, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1679096945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marina Turner, FNP-BC has received a total of $1,490 in payments from pharmaceutical and medical device companies, with $166.60 received in 2024. These payments were reported across 92 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,490).
As a Medicare-enrolled provider, Turner has provided services to 962 Medicare beneficiaries, totaling 1,313 services with total Medicare billing of $65,457. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Nags Head, NC
- Active Since 07/19/2017
- Last Updated 08/15/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679096945
Products in Payments
- VRAYLAR (Drug) $394.85
- UBRELVY (Drug) $138.36
- Ozempic (Drug) $130.44
- UPTRAVI (Drug) $107.74
- AUSTEDO (Drug) $102.27
- QULIPTA (Drug) $87.23
- JARDIANCE (Drug) $72.24
- LEQVIO (Drug) $56.58
- ENTRESTO (Drug) $49.53
- Rybelsus (Drug) $45.26
- WaveWriter Alpha Prime 16 (Device) $37.21
- TRULICITY (Drug) $28.63
- RYBELSUS (Drug) $26.38
- FARXIGA (Drug) $25.27
- GLASSIA (Biological) $25.05
- FREESTYLE LIBRE 2 (Device) $20.18
- TRADJENTA (Drug) $20.18
- INGREZZA (Drug) $19.71
- NEXLETOL (Drug) $17.94
- AJOVY (Biological) $17.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Nags Head
Mrs. Erin Devanney, Fnp-C, FNP-C
Family — Payments: $2,057
Lori Lancsek
Family — Payments: $1,235
Ms. Patricia Johnson, F.n.p., C.n.m, F.N.P., C.N.M
Family — Payments: $282.18
Amanda Williams, Np-C, NP-C
Family — Payments: $245.54
Katherine Caton, Np, NP
Family — Payments: $122.56
Christine Coleman, Np, NP
Family — Payments: $79.15